Ivabradine and Atrial Fibrillation Incidence

Kibum Kim, Jasmeen Keur, Halie Anderson, Przemysław B. Radwański, Mark A. Munger

Open source

DOI
10.1016/j.jacadv.2025.102282
Published
2025-12
Container
JACC: Advances
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacadv.2025.102282,
  title = {Ivabradine and Atrial Fibrillation Incidence},
  author = {Kibum Kim and Jasmeen Keur and Halie Anderson and Przemysław B. Radwański and Mark A. Munger},
  year = {2025},
  journal = {JACC: Advances},
  doi = {10.1016/j.jacadv.2025.102282},
  url = {https://doi.org/10.1016/j.jacadv.2025.102282}
}

RIS

TY  - JOUR
TI  - Ivabradine and Atrial Fibrillation Incidence
AU  - Kibum Kim
AU  - Jasmeen Keur
AU  - Halie Anderson
AU  - Przemysław B. Radwański
AU  - Mark A. Munger
PY  - 2025
JO  - JACC: Advances
DO  - 10.1016/j.jacadv.2025.102282
UR  - https://doi.org/10.1016/j.jacadv.2025.102282
ER  - 

APA

Kim, K., Keur, J., Anderson, H., Radwański, P. B., & Munger, M. A. (2025). Ivabradine and Atrial Fibrillation Incidence. JACC: Advances. https://doi.org/10.1016/j.jacadv.2025.102282

Source records